Evidence map›Paper›PMID 28212558›Full record

ArticleOncotarget2017

Ataxin-1 regulates epithelial-mesenchymal transition of cervical cancer cells.

A-Ram Kang, Hyoung-Tae An, Jesang Ko, Seongman Kang

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Role of Ubiquitin-regulated EMT in Cancer Metastasis and Chemoresistance.International journal of biological sciences · 2025
    Review
  7. Brain communications · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The lncRNA HOTAIR: a pleiotropic regulator of epithelial cell plasticity.Journal of experimental & clinical cancer research : CR · 2023
    Review
  13. Article
  14. Differential effects of Wnt-β-catenin signaling in Purkinje cells and Bergmann glia in spinocerebellar ataxia type 1.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Epigenetic control of ataxin-1 in multiple sclerosis.Annals of clinical and translational neurology · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

A-Ram KangDivision of Life Sciences, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Hyoung-Tae AnDivision of Life Sciences, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Jesang KoDivision of Life Sciences, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Seongman KangDivision of Life Sciences, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.
Korea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mutant form of the protein ataxin-1 (ATXN1) causes the neurodegenerative disease spinocerebellar ataxia type-1. Recently, ATXN1 was reported to enhance E-cadherin expression in the breast cancer cell line MCF-7, suggesting a potential association between ATXN1 and cancer development. In the present study, we discovered a novel mechanism through which ATXN1 regulates the epithelial-mesenchymal transition (EMT) of cancer cells. Hypoxia-induced upregulation of the Notch intracellular domain expression decreased ATXN1 expression via MDM2-associated ubiquitination and degradation. In cervical cancer cells, ATXN1 knockdown induced EMT by directly regulating Snail expression, leading to matrix metalloproteinase activation and the promotion of cell migration and invasion. These findings provide insights into a novel mechanism of tumorigenesis and will facilitate the development of new and more effective therapies for cancer.

Indexed as

Ataxin-1Cell HypoxiaCell Line, TumorEpithelial-Mesenchymal TransitionFemaleHEK293 CellsHeLa CellsHumansMatrix MetalloproteinasesProteinsProto-Oncogene Proteins c-mdm2Signal TransductionSnail Family Transcription FactorsTransfectionUterine Cervical NeoplasmsAtaxin-1ATXN1 protein, humanCRCT1 protein, humanMatrix MetalloproteinasesMDM2 protein, humanProteinsProto-Oncogene Proteins c-mdm2Snail Family Transcription FactorsATXN1cervical cancerepithelial–mesenchymal transitionNotch intracellular domain

Identifiers

PMID28212558
PMCPMC5392324
OpenAlexW2588136066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.